Beyond the Bridge

UNCG Author/Contributor (non-UNCG co-authors, if there are any, appear on document)
Donald D. Kautz, Associate Professor (Creator)
The University of North Carolina at Greensboro (UNCG )
Web Site:

Abstract: Left ventricular assist devices (LVADs) implanted for patients as destination therapy have been shown to improve quality of life and survival, improve functional status, and prolong survival in patients with end-stage heart failure.[1,2] The indications for LVADs include bridge to recovery for patients who need short-term support, bridge to transplant for patients awaiting a heart transplant, and destination therapy for patients ineligible for cardiac transplantation. Originally developed as a bridge to heart transplant, permanent LVAD implantation as destination therapy is the fastest growing indication for device implantation, particularly as the population ages and more patients are diagnosed with end-stage heart failure (see What's an LVAD? and When an LVAD is needed).[1]

Additional Information

Nursing 2013 Critical Care, 8(6), 32-37
Language: English
Date: 2013
Left Ventricular Assist Devices, Destination Therapy, Nursing

Email this document to